Advent Capital Management’s Manchester United MANU Stock Holding History

Advent Capital Management’s Portfolio MANU Stock Details MANU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,000	Closed	-$99K	–	201
2023 Q3	$99K	Sell	5,000 -5,000	-50%	-$109K	﹤0.01%	194
2023 Q2	$244K	Buy	+10,000	New	+$207K	﹤0.01%	221

Other funds holding MANU

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advent Capital Management's MANU Position: Q4 2023 in Review

Advent Capital Management sold out of Manchester United (MANU) in Q4 2023, closing a stake of 5,000 shares — an estimated $99K sold.

Advent Capital Management first reported a position in MANU in Q2 2023 and held it in 2 quarters. The position peaked at $244K in Q2 2023. 117 funds tracked by Wall St. Rank hold MANU as of Q4 2023.

Advent Capital Management reported no remaining Manchester United position as of Q4 2023 after selling out during the quarter.
Advent Capital Management sold 5,000 Manchester United shares in Q4 2023, an estimated $99K.
Advent Capital Management first reported a position in Manchester United in Q2 2023 and held it in 2 quarters.
Advent Capital Management's Manchester United position peaked at $244K in Q2 2023.
117 funds tracked by Wall St. Rank held Manchester United as of Q4 2023.

Based on Advent Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.